You have 9 free searches left this month | for more free features.

Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 1 (2)

Sponsor

Pfizer (2)

Collaborator

Intervention

pf-07284890 (2)

binimetinib (1)

encorafenib (1)

midazolam (1)

pf-07799544 (1)

pf-07799933 (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

pf-07284890

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Melanoma, Glioma, Thyroid Cancer Trial (PF-07799544, PF-07284890, PF-07799933)

Not yet recruiting

Melanoma
+6 more

PF-07799544
+3 more

(no location specified)

Sep 9, 2022

Malignant Melanoma, NSCLC, Brain Tumors, Primary Trial in United States (PF-07284890, Binimetinib, Midazolam)

Recruiting

Malignant Melanoma
+4 more

PF-07284890
+2 more

Duarte, California
+71 more

Dec 29, 2022